Surgical Hub

Wockhardt’s insulin glargine, branded as Glaritus, is a long-acting basal insulin analog (100 IU/ml) designed for once-daily subcutaneous injection to manage type 1 and type 2 diabetes. It provides continuous 24-hour glucose control and is proven bioequivalent to Lantus. Available in vials, cartridges, and disposable pens, it is typically used alongside diet and exercise. Wockhardt – Diabetes +4Key Details for Glaritus (Insulin Glargine):

• Mechanism: Provides a slow, steady release of insulin to cover basal metabolic needs, reducing blood sugar fluctuations throughout the day.
• Administration: Subcutaneous (SC) injection, usually once daily, often in the abdomen, thigh, or upper arm. It is recommended to rotate injection sites to prevent lipodystrophy (skin thickening/pits).
• Forms Available: 3ml Cartridges, 3ml Disposable Pens (Dispopen), and Vials.
• Common Side Effects: Hypoglycemia (low blood sugar), injection site reactions (pain, redness, swelling), weight gain, and allergic reactions.
• Key Considerations: It should not be used in a pump or mixed with other insulins in the same syringe. Patients with renal or hepatic impairment should use it with caution. Wockhardt – Diabetes +4

Glaritus is designed to improve glycemic control (HbA1c levels) and can be used in combination with oral anti-diabetic medications or rapid-acting insulin. Apollo Pharmacy +1Note: Always use this medication under strict medical supervision and follow a proper diet and exercise plan.